Exact Sciences
EXAS
#1890
Rank
C$11.23 B
Marketcap
$60.49
Share price
-3.91%
Change (1 day)
-36.35%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2023 (TTM): -$2.14

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is -$2.25. In 2022 the company made an earnings per share (EPS) of -$5.03 a decrease over its 2021 EPS that were of -$4.92.

EPS history for Exact Sciences from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.14-57.57%
2022-$5.032.31%
2021-$4.92-37.09%
2020-$7.82674.65%
2019-$1.01-50.69%
2018-$2.0544%
2017-$1.42-39.39%
2016-$2.35-2.94%
2015-$2.4237.1%
2014-$1.7679.71%
2013-$0.98-21.59%
2012-$1.2562.96%
2011-$0.7792.86%
2010-$0.40-3.45%
2009-$0.41-19.44%
2008-$0.51-18.18%
2007-$0.63-10.2%
2006-$0.70-10.91%
2005-$0.78-24.66%
2004-$1.04-51.33%
2003-$2.13-7.41%
2002-$2.3011.72%
2001-$2.06

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$4.32 91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.48-121.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.57-74.77%๐Ÿ‡บ๐Ÿ‡ธ USA
-$72.36 3,110.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.52-300.57%๐Ÿ‡ซ๐Ÿ‡ท France